Dr. Samantha South, PhD, MBA, GAICD, boasts a distinguished career as a Founding Director at Argenica Therapeutics, where she serves as Vice President of Nonclinical Development. With a background as a Commercialisation Manager at prestigious institutions like QUT and UWA, Dr. South has played pivotal roles as a Director in several UWA spin-out companies, including MiReven Pty Ltd, Eridan Technologies Pty Ltd, OxiDx Pty Ltd, OncoRes Medical Pty Ltd, and Rage Biotech Pty Ltd. Prior to her current roles, Dr. South has also made significant contributions in preclinical and regulatory capacities at CROs such as TetraQ and GZP.

Dr. South has a proven ability to guide preclinical assets to clinical readiness and craft effective drug development strategies for companies in both listed and non-listed environments. With her impressive track record in navigating the complexities of biotech development, her leadership and strategic insights are poised to greatly contribute to Reliis’ pursuit of innovation and clinical success.